4//SEC Filing
Shah Smital 4
Accession 0000899243-21-027014
CIK 0001815776other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 7:00 PM ET
Size
8.7 KB
Accession
0000899243-21-027014
Insider Transaction Report
Form 4
Shah Smital
Director
Transactions
- Purchase
Common Stock
2021-06-29$17.00/sh+5,882$99,994→ 5,882 total(indirect: See footnote) - Award
Stock Option (right to buy)
2021-04-15+93,585→ 93,585 totalExercise: $7.23Exp: 2031-04-14→ Common Stock (93,585 underlying)
Footnotes (4)
- [F1]These shares are held by the Martins Shah Family Trust of which the Reporting Person and her spouse are trustees. The Reporting Person disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
- [F2]On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.
- [F3]This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
- [F4]1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on the last day of each calendar month after April 12, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase.
Documents
Issuer
Graphite Bio, Inc.
CIK 0001815776
Entity typeother
Related Parties
1- filerCIK 0001808821
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 7:00 PM ET
- Size
- 8.7 KB